(Q36452385)

14 August 2017

Ribonucleoside 3'-phosphates as pro-moieties for an orally administered drug (English)

1 reference

14 August 2017

Ronald T Raines

5

0 references

Nicholas A McGrath

series ordinal

3

object named as

Nicholas A McGrath

1 reference

14 August 2017

1

Michael J Palte

1 reference

14 August 2017

Amy K F Davis

2

1 reference

PMC publication ID

3516917

14 August 2017

Carol A Spiegel

series ordinal

4

1 reference

14 August 2017

13 July 2012

1 reference

14 August 2017

1 reference

14 August 2017

7

1 reference

14 August 2017

8

1 reference

14 August 2017

1361-1364

1 reference

Ribonuclease-Activated Cancer Prodrug

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Oral drug delivery systems comprising altered geometric configurations for controlled drug delivery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Rational design and evaluation of mammalian ribonuclease cytotoxins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Microfabricated particulate drug-delivery systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

A prodrug approach to improve the physico-chemical properties and decrease the genotoxicity of nitro compounds

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Bovine pancreatic ribonuclease: fifty years of the first enzymatic reaction mechanism

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Applications of polymeric nanocapsules in field of drug delivery systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Critical factors in the release of drugs from sustained release hydrophilic matrices.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Prodrug design to improve pharmacokinetic and drug delivery properties: challenges to the discovery scientists

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

The eight human "canonical" ribonucleases: molecular diversity, catalytic properties, and special biological actions of the enzyme proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Metronidazole is still the drug of choice for treatment of anaerobic infections

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Drug delivery from ordered mesoporous matrices.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Prodrugs: design and clinical applications.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

When poor solubility becomes an issue: from early stage to proof of concept

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

The structure of ribonucleic acid. I. Cyclic nucleotides produced by ribonuclease and by alkaline hydrolysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Drug-like properties and the causes of poor solubility and poor permeability

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Clindamycin, metronidazole, and chloramphenicol

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Pharmacokinetics and pharmacodynamics of estramustine phosphate

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

U-3'-BCIP: a chromogenic substrate for the detection of RNase A in recombinant DNA expression systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

The bioavailability and therapeutic effectiveness of prednisolone acetate vs. prednisolone sodium phosphate: a 20-year review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Experimental charge measurement at leaving oxygen in the bovine ribonuclease A catalyzed cyclization of uridine 3'-phosphate aryl esters

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3516917

Value of general Acid-base catalysis to ribonuclease a.

30 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.201200243

Acid/azole complexes as highly effective promoters in the synthesis of DNA and RNA oligomers via the phosphoramidite method

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.201200243

Energetics of Catalysis by Ribonucleases: Fate of the 2',3'-Cyclic Phosphodiester Intermediate

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1002%2FCMDC.201200243

Inhibition of ribonuclease by diethyl pyrocarbonate and other methods

21 January 2018

1 reference

12 December 2020

Purification and immunological characterization of human pancreatic ribonuclease

1 reference

12 December 2020

The role of 2',3'-cyclic phosphodiesters in the bovine pancreatic ribonuclease A catalysed cleavage of RNA: intermediates or products?

1 reference

12 December 2020

Creating a ribonuclease-free environment.

1 reference

12 December 2020

Research on pancreatic ribonuclease. I. The inhibition of cyclic phospho-diesterase activity of bovine pancreatic ribonuclease by several substrate analogues

1 reference

12 December 2020

Identifiers

DOI

10.1002/CMDC.201200243

1 reference

14 August 2017

1 reference

PMC publication ID

3516917

14 August 2017

PubMed publication ID

22807330

1 reference

PMC publication ID

3516917